Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Current Assets (2016 - 2025)

Marimed (MRMD) has disclosed Current Assets for 15 consecutive years, with $59.3 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 10.8% to $59.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.3 million through Dec 2025, up 10.8% year-over-year, with the annual reading at $59.3 million for FY2025, 10.8% up from the prior year.
  • Current Assets for Q4 2025 was $59.3 million at Marimed, down from $60.1 million in the prior quarter.
  • The five-year high for Current Assets was $60.1 million in Q3 2025, with the low at $31.7 million in Q1 2021.
  • Average Current Assets over 5 years is $50.5 million, with a median of $53.3 million recorded in 2024.
  • The sharpest move saw Current Assets surged 215.07% in 2021, then dropped 17.88% in 2022.
  • Over 5 years, Current Assets stood at $44.6 million in 2021, then fell by 1.05% to $44.1 million in 2022, then rose by 16.5% to $51.4 million in 2023, then rose by 4.04% to $53.5 million in 2024, then grew by 10.8% to $59.3 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $59.3 million, $60.1 million, and $57.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.